Metropolitan Life Insurance Company (MetLife)’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,198
| Closed | -$88.4K | – | 1149 |
|
|
2024
Q1 | $88.4K | Hold |
2,198
| – | – | ﹤0.01% | 1118 |
|
|
2023
Q4 | $56K | Sell |
2,198
-288
| -12% | -$7.33K | ﹤0.01% | 1388 |
|
|
2023
Q3 | $34.6K | Buy |
2,486
+352
| +16% | +$4.89K | ﹤0.01% | 1601 |
|
|
2023
Q2 | $49.1K | Hold |
2,134
| – | – | ﹤0.01% | 1426 |
|
|
2023
Q1 | $63.2K | Sell |
2,134
-246
| -10% | -$7.29K | ﹤0.01% | 1257 |
|
|
2022
Q4 | $59.4K | Buy |
2,380
+95
| +4% | +$2.37K | ﹤0.01% | 1358 |
|
|
2022
Q3 | $49.7K | Hold |
2,285
| – | – | ﹤0.01% | 1461 |
|
|
2022
Q2 | $45K | Hold |
2,285
| – | – | ﹤0.01% | 1573 |
|
|
2022
Q1 | $96.7K | Sell |
2,285
-6,981
| -75% | -$295K | ﹤0.01% | 1215 |
|
|
2021
Q4 | $588K | Hold |
9,266
| – | – | 0.01% | 1316 |
|
|
2021
Q3 | $544K | Buy |
9,266
+704
| +8% | +$41.4K | 0.01% | 1404 |
|
|
2021
Q2 | $415K | Buy |
8,562
+5,383
| +169% | +$261K | 0.01% | 1634 |
|
|
2021
Q1 | $124K | Hold |
3,179
| – | – | ﹤0.01% | 2330 |
|
|
2020
Q4 | $197K | Buy |
+3,179
| New | +$197K | ﹤0.01% | 1945 |
|